Clinical effects of San'ao Decoction combined with salbutamol on patients with cough variant asthma
10.3969/j.issn.1001-1528.2023.12.016
- VernacularTitle:三拗汤联合沙丁胺醇对咳嗽变异型哮喘患者的临床疗效
- Author:
Yan-Jun ZHANG
1
;
Ju LIU
;
Xiang-Cai KONG
;
Ji-Chao JIN
;
Ming-Xue BAI
Author Information
1. 郑州市中医院,河南 郑州 450003
- Keywords:
San'ao Decoction;
salbutamol;
cough variant asthma
- From:
Chinese Traditional Patent Medicine
2023;45(12):3954-3958
- CountryChina
- Language:Chinese
-
Abstract:
AIM To explore the clinical effects of San'ao Decoction combined with salbutamol on patients with cough variant asthma.METHODS Eighty patients were randomly assigned into control group(40 cases)for 3-month administration of salbutamol,and observation group(40 cases)for 3-month administration of both San'ao Decoction and mifepristone.The changes in clinical efficacy,TCM syndrome scores,serum MMP-9,VEGF and sex hormones(E2,FSH,PRL)and incidence of adverse reactions were detected.The changes in clinical efficacy,EOS,SIgG4,TIgE,Eotaxin,NKA,LTD4,IL-27,SP,R5-R20,Fres,R5,Zrs,PEF diurnal variation rate,FEF25,PEF,ACT score,PAQLQ score,recurrence rate and incidence of adverse reactions were detected.RESULTS The observation group demonstrated higher total effective rate than the control group(P<0.05),along with lower recurrence rate(P<0.05).After the treatment,the two groups displayed decreased EOS,TIgE,Eotaxin,NKA,LTD4,SP,R5-R20,Fres,R5,Zrs and PEF diurnal variation rate(P<0.05),and increased SIgG4,IL-27,FEF25,PEF,ACT score,PAQLQ score(P<0.05),especially for the observation group(P<0.05).No significant difference in incidence of adverse reactions was found between the two groups(P>0.05).CONCLUSION For the patients with cough variant asthma,San'ao Decoction combined with salbutamol can improve EOS,TIgE,Eotaxin,SIgG4 levels and airway resistance indices,lung function indices,regulate neurogenic mediators,alleviate airway inflammation injury,enhance life quality,and reduce recurrence rate.
